The Center for Advancing Innovation and MedImmune have partnered to launch the Freedom from Cancer Startup Challenge (FCSC). The FCSC will feature risk mitigated, and commercially viable inventions from leading research organizations. Continue reading
Category Archives: AZBio News
AZBio In The Loop for the week of February 12, 2018
News and events for Arizona’s Biotech Community
|
AZBio CEO Joins Bob Roth on Health Futures
Joan Koerber-Walker, president & CEO of AZBio, joined Bob Roth, Managing Partner of Cypress Homecare Solutions, to discuss the exciting things happening in Arizona’s bioscience and healthcare community on HEALTH FUTURES radio show.Continue reading
bioSyntagma Awarded NSF Phase II Small Business Research Grant
Phoenix, AZ— bioSyntagma, LLC, a developer of life science tools for single and multi-cell analysis announced today it has been has been awarded a National Science Foundation (NSF) Phase II Small Business Innovation Research (SBIR) grant of $735,139.Continue reading
SMS Archiving Technology Patent Awarded to CellTrust
SMS archiving technology patented by CellTrust is fundamental for successful e-compliance enforcement for the highly regulated financial services, government and healthcare industries.Continue reading
AZBio In the Loop for the Week of February 5, 2018
News and events for Arizona’s Biotech Community
|
UA Cancer Center Team Targets Tumor Suppressor to Treat ‘Triple-Negative’ Breast Cancer
A team led by UA Cancer Center researchers Agnieszka Witkiewicz, MD, and Erik Knudsen, PhD, screened for drugs that could target triple-negative breast cancer tumors, producing several new therapeutic candidates for this difficult-to-treat cancer.Continue reading
GenoSensor moves into education sector
A Tempe bioscience firm selling its DNA analysis kits to 25 countries worldwide is expanding into the education sector.Continue reading
FDA Allows a Phase II Clinical Trial in Stroke for NuvOx Pharma’s DDFPe
NuvOx Pharma, a clinical stage biotechnology company, announces that the FDA has allowed a Phase II clinical trial in 60 stroke patients to proceed to test NuvOx’s investigational drug product, dodecafluoropentane emulsion (DDFPe). Continue reading
Hoolest wins top prize at ASU Open
An Arizona State University team won $100,000 at the ASU Innovation Open on Friday to fund their business, which makes a device that relieves anxiety.Continue reading